-
A randomized prospective study on the clinical effect of two treatments on keloids
- SUN Yukai, LI Zhonghua, WANG Haiqin, LU Changhui, YANG Bo, WANG Yimin
-
JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES). 2014, 52(8):
85-89.
doi:10.6040/j.issn.1671-7554.0.2014.153
-
Abstract
(
1254 )
PDF (1677KB)
(
329
)
Save
-
References |
Related Articles |
Metrics
Objective To evaluate the effect of two treatment approaches on keloids: fractional CO2 laser combined with 32P applicator, and fractional CO2 laser combined with intralesional injection of compound betamethasone. Methods A total of 70 patients were divided into two groups: group A (n=36) treated with fractional CO2 laser combined with 32P applicator, and group B (n=34) treated with fractional CO2 laser combined with intralesional injection of compound betamethasone. All patients received fractional CO2 laser therapy first and then recombinant human epidermal growth factor gel. After the wound healed, patients in group A received 32P applicator therapy, 0.4~0.8 MBQ/cm2 for 96 hours; patients in group B received compound betamethasone injection therapy, once every month for 3 times. The clinical effect, symptoms, satisfaction and ratio of side effects between the two groups were compared. Results The cure rate and satisfaction in group A were, which were significantly higher than those in group B(χ2=5.884, t=2.193, P<0.05). The Vancouver Scar Scale (VSS) scores, pain scores, and itch scores were significantly improved in both groups after treatment (t=30.070, 14.797, 11.889; t=18.049, 10.016, 8.290, P<0.01); the above items in group A were significantly lower than those in group B after comprehensive intervention (t=5.861, 5.480, 3.069, P<0.01). Conclusion Fractional CO2 laser combined with 32P applicator is highly effective on keloids with satisfactory clinical results. However, the technique still needs improvement.